(Q82598584)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Silibinin monotherapy prevents graft infection after orthotopic liver transplantation in a patient with chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

orthotopic liver transplantation

17 January 2020

main subject

1 reference

1 reference

1 reference

1 reference

Sandra Beinhardt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Susanne Rasoul-Rockenschaub

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Thomas Matthias Scherzer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Peter Ferenci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21106270

2 September 2024

publication date

14 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 January 2020

https://doi.org/10.1016/j.jhep.2010.09.009

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21106270

https://api.elsevier.com/content/article/PII:S0168827810008998?httpAccept=text/xml

2 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.09.009

https://api.elsevier.com/content/article/PII:S0168827810008998?httpAccept=text/plain

2 September 2024

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.09.009

2 September 2024

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

591-2; author reply 592-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy

17 January 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.09.009

Silibinin is a potent antiviral agent in patients with chronic hepatitis C not responding to pegylated interferon/ribavirin therapy.

2 September 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.09.009

Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase

2 September 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.JHEP.2010.09.009

2 September 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21106270%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference